PatentMay 8, 2026, 09:17 AM
ENvue Medical Receives Patent Allowance for Cannabinoid Delivery System
AI Summary
ENvue Medical, Inc. announced that the USPTO has issued a Notice of Allowance for U.S. Patent Application No. 17/025,969. This patent covers a novel drug delivery system utilizing the Company's proprietary surface acoustic wave (SAW) technology to enhance transdermal delivery of cannabinoid-based therapeutics. The allowance provides broad intellectual property protection and is expected to expand ENvue's platform into a new therapeutic category, positioning the company favorably in the growing cannabinoid market.
Key Highlights
- USPTO issued a Notice of Allowance for U.S. Patent Application No. 17/025,969.
- The patent covers a novel drug delivery system using proprietary surface acoustic wave (SAW) technology.
- It enhances transdermal delivery of cannabinoid-based therapeutics.
- Broad intellectual property protection includes transdermal patch configurations and SAW-generating platforms.
- The technology aims to improve therapeutic administration and enable strategic collaborations.
- CEO Doron Besser stated it validates a meaningful expansion of the SAW platform into a new therapeutic category.
Price Impact
More from FEED